Penn Medicine Provider
Dermatology
Sara S. Samimi, MD
5.0
(639)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Radnor
View 1 additional location
Schedule onlineCall 215-662-2737

About me

  • Associate Program Director
  • Vice Chair of Quality and Safety
  • Associate Professor of Clinical Dermatology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Pennsylvania Hospital
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

640 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
good visit
May 2025
5.0
5.0
she's the best !
May 2025
5.0
5.0
dr. samimi is awesome!
May 2025
5.0
5.0
she is wonderful

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Samimi is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Himeless JR, Holton J, Vittorio C, Rook A, Haun P, Villasenor-Park J, Samimi S, Kim E. Recent trends in skin directed and self-administered systemic treatment costs in the United States for Cutaneous T Cell Lymphoma , JAMA Dermatol, 88(3): 2023,680-683

Weiner DM, Clark AK, Bhansali R, Pappas-Taffer L, Barta SK, Villasenor-Park J, Haun PL, Vittorio CC, Rook AH, Kim EJ, Samimi SS. Usage and Safety of Topical Tacrolimus in Patients with Mycosis Fungoides , Clin Exp Dermatol., 47(6): 2022,1200-1201

Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP. Implementing Patient Safety and Quality Improvement in Dermatology Part 2: Quality Improvement Science , J Am Acad Dermatol., S0190-9622(22): 2022,00208-0

Marsch A, Khodosh R, Porter M, Raad J, Samimi S, Schultz B, Chaney Strowd L, Vera L, Wong E, Smith GP. Implementing Patient Safety and Quality Improvement in Dermatology Part 1: Patient Safety Science , J Am Acad Dermatol., S0190-9622(22): 2022,00207-9

Wanat KA, Perelygina L, Chen MH, Hao L, Abernathy E, Bender NR, Shields BE, Wilson BDE, Crosby D, Routes J, Samimi SS, Haun PL, Sokumbi O, Icenogle JP, Sullivan KE, Rosenbach M, Drolet BA. Association of persistent rubella virus with idiopathic skin granulomas in clinically immunocompetent adults , JAMA Dermatol, 158(6): 2022,626-33

Samimi S, Choi J, Rosman IS, Rosenbach M. Impact of COVID-19 on Dermatology Residency , Dermatol Clin., 39(4): 2021,609-618

Weiner DM, Clark AK, Moon AT, Haun PL, Samimi SS. A case of nevoid follicular mucinosis in a child , JAAD Case Rep, 18: 2021,29-32

Shields B, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, Chen M, Hao L, Icenogle J, Drolet B, Wilson B, Bryer J, England R, Blumberg E, Wanat K, Sullivan K, Rosenbach M. Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency , JAMA Dermatol., 157(7): 2021,842-847

Lewis D, Haun P, Samimi S, Vittorio C, Villasenor-Park J, Barta S, Landsburg D, Svoboda J, Nasta S, Schuster S, Rook A, Kim E. Brentuximab Vedotin for relapsed/refractory sezary syndrome: a single center experience , JAMA Dermatol., 157(3): 2021,317-321

Durgin J, Jariwala N, Wysocka M, Zhang K, Maity A, Benoit B, Plastaras J, Lewis D, Rosenthal J, Teague J, Berg S, Del Guzzo C, Kim E, Vittorio C, Haun P, Samimi S, illasenor-Park J, Clark R, Rook A. Low or Conventional-Dose TSEBT with Concomitant Immunotherapy Can Produce Durable Responses in Sezary Syndrome: Clinical, Immunological and moledcular Analysis. , JAMA Dermatol., 157(1): 2021,90-95